The GeneXpert diagnostic testing technology from the US corporation Cepheid, and its parent company Danaher, has revolutionised rapid, accurate diagnosis of tuberculosis (TB) and other diseases, since entering the market in 2010. Yet, due to the high cost of the GeneXpert test cartridges, many countries are not able to scale up testing for all people who need lifesaving diagnosis and subsequent treatment.
In 2021, we celebrate the centenary of the discovery of insulin by the Canadian scientists Frederick Banting and Charles Best, followed a year later by the first person receiving insulin treatment. This ground-breaking milestone ...
In December 2018 it was reported that close to 300 people had been bitten by snakes in a rural area of Kenya, Baringo county, north west of Nairobi – this ‘outbreak’ seemed to represent a spike in envenomings that had not been widely ...
Three women - a patient, a doctor and a lawyer - share their stories about being affected by the struggle for access to medicines and their work to protect and increase access to medicines for all.
Phumeza and Nandita suffered permanent hearing loss because of toxic drugs used to treat their drug-resistant TB. Now they’re working to ensure that this doesn’t happen to anyone else.
In April 2018, MSF opened a post-operative care hospital in this city, to provide services for people injured by violent or accidental trauma during the recent conflict. Soon after the activities started, data showed that more than one ...
Activists interrupted the opening ceremony of the 49th Union World Conference on Lung Health in The Hague today, to call on US pharmaceutical corporation Johnson & Johnson (J&J) to cut the price of the TB drug bedaquiline in half, to ...